{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:31:40Z","timestamp":1793460700553,"version":"4.5.0"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41582-023-00864-5","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:02:24Z","timestamp":1693314144000},"page":"583-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The translational potential of cholesterol-based therapies for neurological disease"],"prefix":"10.1038","volume":"19","author":[{"given":"Marta","family":"Valenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Birolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-4917","authenticated-orcid":false,"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1471-4159.1995.64020895.x","volume":"64","author":"H Jurevics","year":"1995","unstructured":"Jurevics, H. & Morell, P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64, 895\u2013901 (1995).","journal-title":"J. Neurochem."},{"key":"864_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy, J. M. & Turley, S. D. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375\u20131397 (2004).","journal-title":"J. Lipid Res."},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/BC.2009.035","volume":"390","author":"JM Dietschy","year":"2009","unstructured":"Dietschy, J. M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 390, 287\u2013293 (2009).","journal-title":"Biol. Chem."},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"F Maxfield","year":"2005","unstructured":"Maxfield, F. & Tabas, I. Role of cholesterol and lipid organization in disease. Nature 438, 612\u2013621 (2005).","journal-title":"Nature"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"D Mauch","year":"2001","unstructured":"Mauch, D. et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354\u20131357 (2001).","journal-title":"Science"},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1074\/mcp.M600161-MCP200","volume":"5","author":"JY Jia","year":"2006","unstructured":"Jia, J. Y. et al. Quantitative proteomics analysis of detergent-resistant membranes from chemical synapses: evidence for cholesterol as spatial organizer of synaptic vesicle cycling. Mol. Cell. Proteom. 5, 2060\u20132071 (2006).","journal-title":"Mol. Cell. Proteom."},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","volume":"127","author":"S Takamori","year":"2006","unstructured":"Takamori, S. et al. Molecular anatomy of a trafficking organelle. Cell 127, 831\u2013846 (2006).","journal-title":"Cell"},{"key":"864_CR8","doi-asserted-by":"publisher","first-page":"15856","DOI":"10.1523\/JNEUROSCI.4132-10.2010","volume":"30","author":"JS Dason","year":"2010","unstructured":"Dason, J. S., Smith, A. J., Marin, L. & Charlton, M. P. Vesicular sterols are essential for synaptic vesicle cycling. J. Neurosci. 30, 15856\u201315865 (2010).","journal-title":"J. Neurosci."},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fnana.2014.00076","volume":"8","author":"CG Dotti","year":"2014","unstructured":"Dotti, C. G., Esteban, J. A. & Ledesma, M. D. Lipid dynamics at dendritic spines. Front. Neuroanat. 8, 76 (2014).","journal-title":"Front. Neuroanat."},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1523\/JNEUROSCI.23-08-03262.2003","volume":"23","author":"H Hering","year":"2003","unstructured":"Hering, H., Lin, C.-C. & Sheng, M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23, 3262\u20133271 (2003).","journal-title":"J. Neurosci."},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen, J. A., Halverson-Tamboli, R. A. & Rasenick, M. M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 8, 128\u2013140 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"864_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","volume":"260","author":"I Bj\u00f6rkhem","year":"2006","unstructured":"Bj\u00f6rkhem, I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Int. Med. 260, 493\u2013508 (2006).","journal-title":"J. Int. Med."},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1073\/pnas.0700899104","volume":"104","author":"A Radhakrishnan","year":"2007","unstructured":"Radhakrishnan, A., Ikeda, Y., Joo Kwon, H., Brown, M. S. & Goldstein, J. L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl Acad. Sci. USA 104, 6511\u20136518 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pneurobio.2003.09.004","volume":"71","author":"M Schumacher","year":"2003","unstructured":"Schumacher, M. et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71, 3\u201329 (2003).","journal-title":"Prog. Neurobiol."},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1194\/jlr.R006338","volume":"51","author":"I Bj\u00f6rkhem","year":"2010","unstructured":"Bj\u00f6rkhem, I., Leoni, V. & Meaney, S. Genetic connections between neurological disorders and cholesterol metabolism. J. Lipid Res. 51, 2489\u20132503 (2010).","journal-title":"J. Lipid Res."},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.bbalip.2010.03.011","volume":"1801","author":"M Martin","year":"2010","unstructured":"Martin, M., Dotti, C. G. & Ledesma, M. D. Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta 1801, 934\u2013944 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","volume":"10","author":"G Saher","year":"2023","unstructured":"Saher, G. Cholesterol metabolism in aging and age-related disorders. Annu. Rev. Neurosci. 10, 59\u201378 (2023).","journal-title":"Annu. Rev. Neurosci."},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/antiox10121890","volume":"26","author":"E Staurenghi","year":"2021","unstructured":"Staurenghi, E. et al. Cholesterol dysmetabolism in Alzheimer\u2019s disease: a starring role for astrocytes? Antioxidants 26, 1890 (2021).","journal-title":"Antioxidants"},{"key":"864_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-8-1","volume":"8","author":"U F\u00fcnfschilling","year":"2007","unstructured":"F\u00fcnfschilling, U., Saher, G., Xiao, L., M\u00f6bius, W. & Nave, K. A. Survival of adult neurons lacking cholesterol synthesis in vivo. BMC Neurosci. 8, 1 (2007).","journal-title":"BMC Neurosci."},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1523\/JNEUROSCI.1352-11.2012","volume":"32","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling, U. et al. Critical time window of neuronal cholesterol synthesis during neurite outgrowth. J. Neurosci. 32, 7632\u20137645 (2012).","journal-title":"J. Neurosci."},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang, J. & Liu, Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell 6, 254\u2013264 (2015).","journal-title":"Protein Cell"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"819281","DOI":"10.3389\/fcell.2022.819281","volume":"21","author":"Q Shi","year":"2022","unstructured":"Shi, Q., Chen, J., Zou, X. & Tang, X. Intracellular cholesterol synthesis and transport. Front. Cell Dev. Biol. 21, 819281 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem, I. et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 1594\u20131600 (1998).","journal-title":"J. Lipid Res."},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","volume":"78","author":"DW Russell","year":"2009","unstructured":"Russell, D. W., Halford, R. W., Ramirez, D. M., Shah, R. & Kotti, T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 78, 1017\u20131040 (2009).","journal-title":"Annu. Rev. Biochem."},{"key":"864_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","volume":"109","author":"K Nieweg","year":"2009","unstructured":"Nieweg, K. et al. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109, 125\u2013134 (2009).","journal-title":"J. Neurochem."},{"key":"864_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07999","volume":"4","author":"MA Mitsche","year":"2015","unstructured":"Mitsche, M. A., McDonald, J. G., Hobbs, H. H. & Cohen, J. C. Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways. Elife 4, e07999 (2015).","journal-title":"Elife"},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1073\/pnas.90.24.11603","volume":"90","author":"X Hua","year":"1993","unstructured":"Hua, X. et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc. Natl Acad. Sci. USA 90, 1603\u20131607 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: convergent physiology-divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710\u2013730 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"864_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1742-4658.2008.06808.x","volume":"276","author":"N Camargo","year":"2009","unstructured":"Camargo, N., Smit, A. B. & Verheijen, M. H. G. SREBPs: SREBP function in glia\u2013neuron interactions. FEBS J. 276, 628\u2013636 (2009).","journal-title":"FEBS J."},{"key":"864_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.1620506114","volume":"114","author":"HA Ferris","year":"2017","unstructured":"Ferris, H. A. et al. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc. Natl Acad. Sci. USA 114, 1189\u20131194 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza, M. et al. Disruption of astrocyte\u2013neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ. 22, 690\u2013702 (2015).","journal-title":"Cell Death Differ."},{"key":"864_CR32","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1096\/fj.12-205807","volume":"26","author":"N Camargo","year":"2012","unstructured":"Camargo, N. et al. High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J. 26, 4302\u20134315 (2012).","journal-title":"FASEB J."},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/glia.23120","volume":"65","author":"AF van Deijk","year":"2017","unstructured":"van Deijk, A. F. et al. Astrocyte lipid metabolism is critical for synapse development and function in vivo. Glia 65, 670\u2013682 (2017).","journal-title":"Glia"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"3","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 3, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 6, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","volume":"95","author":"H Chai","year":"2017","unstructured":"Chai, H. et al. Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron 95, 531\u2013549 (2017).","journal-title":"Neuron"},{"key":"864_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14198-8","volume":"11","author":"MY Batiuk","year":"2020","unstructured":"Batiuk, M. Y. et al. Identification of region-specific astrocyte subtypes at single cell resolution. Nat. Commun. 11, 1220 (2020).","journal-title":"Nat. Commun."},{"key":"864_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah, O. et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol. Commun. 8, 19 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"864_CR39","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza, M. et al. Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J. Neurosci. 30, 10844\u201310850 (2010).","journal-title":"J. Neurosci."},{"key":"864_CR40","doi-asserted-by":"publisher","first-page":"109308","DOI":"10.1016\/j.celrep.2021.109308","volume":"36","author":"A Benraiss","year":"2021","unstructured":"Benraiss, A. et al. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington\u2019s disease. Cell Rep. 36, 109308 (2021).","journal-title":"Cell Rep."},{"key":"864_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181349","volume":"12","author":"Y Itoh","year":"2017","unstructured":"Itoh, Y. & Voskuhl, R. R. Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson\u2019s disease, and Alzheimer\u2019s disease. PLoS ONE 12, e0181349 (2017).","journal-title":"PLoS ONE"},{"key":"864_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.celrep.2017.12.039","volume":"22","author":"MM Boisvert","year":"2018","unstructured":"Boisvert, M. M., Erikson, G. A., Shokhirev, M. N. & Allen, N. J. The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep. 22, 269\u2013285 (2018).","journal-title":"Cell Rep."},{"key":"864_CR43","doi-asserted-by":"publisher","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","volume":"30","author":"Q Liu","year":"2010","unstructured":"Liu, Q. et al. Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J. Neurosci. 30, 17068\u201317078 (2010).","journal-title":"J. Neurosci."},{"key":"864_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"4","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger, F. W. & Ungerer, N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 4, 357\u2013371 (2011).","journal-title":"Prog. Lipid Res."},{"key":"864_CR45","doi-asserted-by":"publisher","first-page":"30178","DOI":"10.1074\/jbc.272.48.30178","volume":"272","author":"I Bj\u00f6rkhem","year":"1997","unstructured":"Bj\u00f6rkhem, I., L\u00fctjohann, D., Breuer, O., Sakinis, A. & Wennmalm, A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem. 272, 30178\u201330184 (1997).","journal-title":"J. Biol. Chem."},{"key":"864_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37349\/ent.2022.00015","volume":"2","author":"L Qian","year":"2022","unstructured":"Qian, L., Chai, A. B., Gelissen, I. C. & Brown, A. J. Balancing cholesterol in the brain: from synthesis to disposal. Explor. Neuroprot. Ther. 2, 1\u201327 (2022).","journal-title":"Explor. Neuroprot. Ther."},{"key":"864_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13311-019-00731-6","volume":"16","author":"AM Petrov","year":"2019","unstructured":"Petrov, A. M. & Pikuleva, I. A. Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases. Neurotherapeutics 16, 635\u2013648 (2019).","journal-title":"Neurotherapeutics"},{"key":"864_CR48","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/cne.21605","volume":"507","author":"DMO Ramirez","year":"2008","unstructured":"Ramirez, D. M. O., Andersson, S. & Russell, D. W. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507, 1676\u20131693 (2008).","journal-title":"J. Comp. Neurol."},{"key":"864_CR49","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","volume":"96","author":"EG Lund","year":"1999","unstructured":"Lund, E. G., Guileyardo, J. M. & Russell, D. W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl Acad. USA 96, 7238\u20137243 (1999).","journal-title":"Proc. Natl Acad. USA"},{"key":"864_CR50","first-page":"9799","volume":"93","author":"D Lutjohann","year":"1996","unstructured":"Lutjohann, D. et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation (cerebrospinal fluid\/oxysterols\/plasma\/stable isotopes). Med. Sci. 93, 9799\u20139804 (1996).","journal-title":"Med. Sci."},{"key":"864_CR51","doi-asserted-by":"publisher","first-page":"22980","DOI":"10.1074\/jbc.M303415200","volume":"278","author":"EG Lund","year":"2003","unstructured":"Lund, E. G. et al. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980\u201322988 (2003).","journal-title":"J. Biol. Chem."},{"key":"864_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1388-1981(00)00070-6","volume":"1486","author":"S Meaney","year":"2020","unstructured":"Meaney, S., L\u00fctjohann, D., Diczfalusy, U. & Bj\u00f6rkhem, I. Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice. Biochim. Biophys. Acta 1486, 293\u2013298 (2020).","journal-title":"Biochim. Biophys. Acta"},{"key":"864_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","volume":"95","author":"V Leoni","year":"2013","unstructured":"Leoni, V. & Caccia, C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 95, 595\u2013612 (2013).","journal-title":"Biochimie"},{"key":"864_CR54","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","volume":"27","author":"R Courtney","year":"2016","unstructured":"Courtney, R. & Landreth, G. E. LXR regulation of brain cholesterol: from development to disease. Trends Endocrinol. Metab. 27, 404\u2013414 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"864_CR55","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1074\/jbc.M601019200","volume":"281","author":"K Abildayeva","year":"2006","unstructured":"Abildayeva, K. et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281, 12799\u201312808 (2006).","journal-title":"J. Biol. Chem."},{"key":"864_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1471-4159.2004.02183.x","volume":"88","author":"Y Liang","year":"2004","unstructured":"Liang, Y. et al. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 88, 623\u2013634 (2004).","journal-title":"J. Neurochem."},{"key":"864_CR57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2796.2011.02389.x","volume":"270","author":"M Shafaati","year":"2011","unstructured":"Shafaati, M. et al. Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo. J. Intern. Med. 270, 377\u2013387 (2011).","journal-title":"J. Intern. Med."},{"key":"864_CR58","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1073\/pnas.172510899","volume":"99","author":"L Wang","year":"2002","unstructured":"Wang, L. et al. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl Acad. Sci. USA 99, 13878\u201313883 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187168","volume":"12","author":"N Mast","year":"2017","unstructured":"Mast, N. et al. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1). PLoS ONE 12, e0187168 (2017). Erratum in: PLoS ONE 13, e0191058 (2018).","journal-title":"PLoS ONE"},{"key":"864_CR60","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awv384","volume":"139","author":"L Boussicault","year":"2016","unstructured":"Boussicault, L. et al. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease. Brain 139, 953\u2013970 (2016).","journal-title":"Brain"},{"key":"864_CR61","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","volume":"60","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger, F. W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 60, 1158\u20131171 (2003).","journal-title":"Cell. Mol. Life Sci."},{"key":"864_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","volume":"18","author":"G Hussain","year":"2019","unstructured":"Hussain, G. et al. Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis. 18, 26 (2019).","journal-title":"Lipids Health Dis."},{"key":"864_CR63","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.2174\/1570159X19666211111122311","volume":"20","author":"F Lu","year":"2022","unstructured":"Lu, F., Ferriero, M. D. & Jiang, X. Cholesterol in brain development and perinatal brain injury: more than a building block. Curr. Neuropharmacol. 20, 1400\u20131412 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"864_CR64","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature04942","volume":"442","author":"F Yang","year":"2006","unstructured":"Yang, F. et al. An ARC\/mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442, 700\u2013704 (2006).","journal-title":"Nature"},{"key":"864_CR65","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1523\/JNEUROSCI.0170-10.2010","volume":"30","author":"AJ Smith","year":"2010","unstructured":"Smith, A. J., Sugita, S. & Charlton, M. P. Cholesterol-dependent kinase activity regulates transmitter release from cerebellar synapses. J. Neurosci. 30, 6116\u20136121 (2010).","journal-title":"J. Neurosci."},{"key":"864_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20090969","volume":"423","author":"MA Churchward","year":"2009","unstructured":"Churchward, M. A. & Coorssen, J. R. Cholesterol, regulated exocytosis and the physiological fusion machine. Biochem. J. 423, 1\u201314 (2009).","journal-title":"Biochem. J."},{"key":"864_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/71366","volume":"2","author":"C Thiele","year":"2000","unstructured":"Thiele, C., Hannah, M. J., Fahrenholz, F. & Huttner, W. B. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol. 2, 42\u201349 (2000).","journal-title":"Nat. Cell Biol."},{"key":"864_CR68","doi-asserted-by":"publisher","first-page":"740318","DOI":"10.3389\/fnsyn.2021.740318","volume":"13","author":"DN White","year":"2021","unstructured":"White, D. N. & Stowell, M. H. B. Room for two: the synaptophysin\/synaptobrevin complex. Front. Synaptic Neurosci. 13, 740318 (2021).","journal-title":"Front. Synaptic Neurosci."},{"key":"864_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21027-4","volume":"12","author":"WK Man","year":"2021","unstructured":"Man, W. K. et al. The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition. Nat. Commun. 12, 927 (2021).","journal-title":"Nat. Commun."},{"key":"864_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69454-5","volume":"10","author":"M Korinek","year":"2020","unstructured":"Korinek, M. et al. Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission. Sci. Rep. 10, 12651 (2020).","journal-title":"Sci. Rep."},{"key":"864_CR71","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini, J. & Barrantes, F. J. Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta Biomembranes 1788, 2345\u20132361 (2009).","journal-title":"Biochim. Biophys. Acta Biomembranes"},{"key":"864_CR72","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12035-019-01775-7","volume":"57","author":"PA Postila","year":"2020","unstructured":"Postila, P. A. & R\u00f3g, T. A perspective: active role of lipids in neurotransmitter dynamics. Mol. Neurobiol. 57, 910\u2013925 (2020).","journal-title":"Mol. Neurobiol."},{"key":"864_CR73","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/emboj.2012.31","volume":"31","author":"AO Sodero","year":"2012","unstructured":"Sodero, A. O. et al. Cholesterol loss during glutamate-mediated excitotoxicity. EMBO J. 31, 1764\u20131773 (2012).","journal-title":"EMBO J."},{"key":"864_CR74","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham, G. E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682\u2013696 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"864_CR75","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0959-4388(03)00073-4","volume":"13","author":"P Vanhoutte","year":"2003","unstructured":"Vanhoutte, P. & Bading, H. Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr. Opin. Neurobiol. 13, 366\u2013371 (2003).","journal-title":"Curr. Opin. Neurobiol."},{"key":"864_CR76","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15252\/emmm.201303711","volume":"6","author":"MG Martin","year":"2014","unstructured":"Martin, M. G. et al. Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents. EMBO Mol. Med. 6, 902\u2013917 (2014).","journal-title":"EMBO Mol. Med."},{"key":"864_CR77","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0306-4522(98)00537-5","volume":"90","author":"RL Klein","year":"1999","unstructured":"Klein, R. L. et al. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain. Neuroscience 90, 815\u2013821 (1999).","journal-title":"Neuroscience"},{"key":"864_CR78","doi-asserted-by":"crossref","unstructured":"Fantini, J., Epand, R. M., Barrantes, F. J. in Direct Mechanisms in Cholesterol Modulation of Protein Function (eds Rosenhouse-Dantsker, A. & Bukiya, A.) 3\u201325 (Springer, 2019).","DOI":"10.1007\/978-3-030-14265-0_1"},{"key":"864_CR79","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto, P. C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184, 1299\u20131313.e19 (2021).","journal-title":"Cell"},{"key":"864_CR80","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrn2738","volume":"10","author":"L Minichiello","year":"2009","unstructured":"Minichiello, L. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10, 850\u2013860 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"864_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-genom-091212-153412","volume":"15","author":"FM Platt","year":"2014","unstructured":"Platt, F. M. et al. Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease. Annu. Rev. Genomics Hum. Genet. 15, 173\u2013194 (2014).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"864_CR82","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.15252\/embr.201439225","volume":"15","author":"MG Mart\u00edn","year":"2014","unstructured":"Mart\u00edn, M. G., Pfrieger, F. & Dotti, C. G. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 15, 1036\u20131052 (2014).","journal-title":"EMBO Rep."},{"key":"864_CR83","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnmol.2017.00382","volume":"10","author":"F Arenas","year":"2017","unstructured":"Arenas, F., Garcia-Ruiz, C. & Fernandez-Checa, J. C. Intracellular cholesterol trafficking and impact in neurodegeneration. Front. Mol. Neurosci. 10, 382 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"864_CR84","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai, L. et al. Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol. Neurobiol. 58, 2183\u20132201 (2021).","journal-title":"Mol. Neurobiol."},{"key":"864_CR85","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","volume":"13","author":"JS Paulsen","year":"2014","unstructured":"Paulsen, J. S. et al. Prediction of manifest Huntington\u2019s disease with clinical and imaging measures: a prospective observational study. Lancet Neurol. 13, 1193\u20131201 (2014).","journal-title":"Lancet Neurol."},{"key":"864_CR86","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","volume":"11","author":"S Sipione","year":"2002","unstructured":"Sipione, S. et al. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum. Mol. Genet. 11, 1953\u20131965 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR87","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza, M. et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J. Neurosci. 25, 9932\u20139939 (2005).","journal-title":"J. Neurosci."},{"key":"864_CR88","doi-asserted-by":"publisher","first-page":"eaaw8546","DOI":"10.1126\/scitranslmed.aaw8546","volume":"11","author":"B Diaz-Castro","year":"2019","unstructured":"Diaz-Castro, B., Gangwani, M. R., Yu, X., Coppola, G. & Khakh, B. S. Astrocyte molecular signatures in Huntington\u2019s disease. Sci. Transl. Med. 11, eaaw8546 (2019).","journal-title":"Sci. Transl. Med."},{"key":"864_CR89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","volume":"98","author":"M Shankaran","year":"2017","unstructured":"Shankaran, M. et al. Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: a cross-validation study in Q175 knock-in mice. Neurobiol. Dis. 98, 66\u201376 (2017).","journal-title":"Neurobiol. Dis."},{"key":"864_CR90","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/hmg\/ddz298","volume":"29","author":"A di Pardo","year":"2020","unstructured":"di Pardo, A. et al. Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import. Hum. Mol. Genet. 29, 418\u2013431 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR91","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awab186","volume":"144","author":"G Birolini","year":"2021","unstructured":"Birolini, G. et al. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes. Brain 144, 3175\u20133190 (2021).","journal-title":"Brain"},{"key":"864_CR92","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","volume":"16","author":"M Valenza","year":"2007","unstructured":"Valenza, M. et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum. Mol. Genet. 16, 2187\u20132198 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR93","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza, M. et al. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol. Dis. 28, 133\u2013142 (2007).","journal-title":"Neurobiol. Dis."},{"key":"864_CR94","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012519","volume":"12","author":"G Birolini","year":"2020","unstructured":"Birolini, G. et al. Striatal infusion of cholesterol promotes dose\u2010dependent behavioral benefits and exerts disease\u2010modifying effects in Huntington\u2019s disease mice. EMBO Mol. Med. 12, e12519 (2020).","journal-title":"EMBO Mol. Med."},{"key":"864_CR95","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","volume":"330","author":"G Birolini","year":"2021","unstructured":"Birolini, G. et al. Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington\u2019s disease. J. Control. Rel. 330, 587\u2013598 (2021).","journal-title":"J. Control. Rel."},{"key":"864_CR96","doi-asserted-by":"publisher","first-page":"106823","DOI":"10.1016\/j.phrs.2023.106823","volume":"17","author":"G Birolini","year":"2023","unstructured":"Birolini, G. et al. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease. Pharmacol. Res. 17, 106823 (2023).","journal-title":"Pharmacol. Res."},{"key":"864_CR97","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","volume":"15","author":"E Trushina","year":"2006","unstructured":"Trushina, E. et al. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum. Mol. Genet. 15, 3578\u20133591 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR98","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","volume":"115","author":"D del Toro","year":"2010","unstructured":"del Toro, D. et al. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease. J. Neurochem. 115, 153\u2013167 (2010).","journal-title":"J. Neurochem."},{"key":"864_CR99","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","volume":"142","author":"R Kacher","year":"2019","unstructured":"Kacher, R. et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease. Brain 142, 2432\u20132450 (2019).","journal-title":"Brain"},{"key":"864_CR100","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","volume":"34","author":"M Valenza","year":"2011","unstructured":"Valenza, M. & Cattaneo, E. Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci. 34, 474\u2013486 (2011).","journal-title":"Trends Neurosci."},{"key":"864_CR101","first-page":"e505886e9a1968","volume":"4","author":"M Marullo","year":"2012","unstructured":"Marullo, M. et al. Pitfalls in the detection of cholesterol in Huntington\u2019s disease models. PLoS Curr. 4, e505886e9a1968 (2012).","journal-title":"PLoS Curr."},{"key":"864_CR102","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1073\/pnas.1917421117","volume":"117","author":"E Yutuc","year":"2020","unstructured":"Yutuc, E. et al. Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism. Proc. Natl Acad. Sci. USA 117, 5749\u20135760 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24672-x","volume":"12","author":"T Li","year":"2021","unstructured":"Li, T. et al. Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain. Nat. Commun. 12, 4343 (2021).","journal-title":"Nat. Commun."},{"key":"864_CR104","doi-asserted-by":"publisher","first-page":"eabh1623","DOI":"10.1126\/science.abh1623","volume":"376","author":"L Capolupo","year":"2022","unstructured":"Capolupo, L. et al. Sphingolipids control dermal fibroblast heterogeneity. Science 376, eabh1623 (2022).","journal-title":"Science"},{"key":"864_CR105","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/nan.12286","volume":"42","author":"F Kreilaus","year":"2016","unstructured":"Kreilaus, F., Spiro, A. S., McLean, C. A., Garner, B. & Jenner, A. M. Evidence for altered cholesterol metabolism in Huntington\u2019s disease post mortem brain tissue. Neuropathol. Appl. Neurobiol. 42, 535\u2013546 (2016).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"864_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76973-8","volume":"10","author":"GR Phillips","year":"2020","unstructured":"Phillips, G. R. et al. Cholesteryl ester levels are elevated in the caudate and putamen of Huntington\u2019s disease patients. Sci. Rep. 10, 20314 (2020).","journal-title":"Sci. Rep."},{"key":"864_CR107","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni, V. et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain 131, 2851\u20132859 (2008).","journal-title":"Brain"},{"key":"864_CR108","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","volume":"494","author":"V Leoni","year":"2011","unstructured":"Leoni, V. et al. Whole body cholesterol metabolism is impaired in Huntington\u2019s disease. Neurosci. Lett. 494, 245\u2013249 (2011).","journal-title":"Neurosci. Lett."},{"key":"864_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","volume":"55","author":"V Leoni","year":"2013","unstructured":"Leoni, V., Long, J. D., Mills, J. A., di Donato, S. & Paulsen, J. S. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. Neurobiol. Dis. 55, 37\u201343 (2013).","journal-title":"Neurobiol. Dis."},{"key":"864_CR110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nm0309-253","volume":"15","author":"M Katsuno","year":"2009","unstructured":"Katsuno, M., Adachi, H. & Sobue, G. Getting a handle on Huntington\u2019s disease: the case for cholesterol. Nat. Med. 15, 253\u2013254 (2009).","journal-title":"Nat. Med."},{"key":"864_CR111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plipres.2011.11.004","volume":"51","author":"MD Ledesma","year":"2012","unstructured":"Ledesma, M. D., Martin, M. G. & Dotti, C. G. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog. Lipid Res. 51, 23\u201335 (2012).","journal-title":"Prog. Lipid Res."},{"key":"864_CR112","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.1990.tb01889.x","volume":"54","author":"M S\u00f6derberg","year":"1990","unstructured":"S\u00f6derberg, M., Edlund, C., Kristensson, K. & Dallner, G. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54, 415\u2013423 (1990).","journal-title":"J. Neurochem."},{"key":"864_CR113","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","volume":"63","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm, L., Bostr\u00f6m, K., Jungbjer, B. & Olsson, L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 63, 1802\u20131811 (1994).","journal-title":"J. Neurochem."},{"key":"864_CR114","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s004010050717","volume":"94","author":"L Svennerholm","year":"1997","unstructured":"Svennerholm, L., Bostr\u00f6m, K. & Jungbjer, B. Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol. 94, 345\u2013352 (1997).","journal-title":"Acta Neuropathol."},{"key":"864_CR115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2006.04.034","volume":"403","author":"KM Thelen","year":"2006","unstructured":"Thelen, K. M., Falkai, P., Bayer, T. A. & L\u00fctjohann, D. Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci. Lett. 403, 15\u201319 (2006).","journal-title":"Neurosci. Lett."},{"key":"864_CR116","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1091\/mbc.e07-09-0897","volume":"19","author":"MG Martin","year":"2008","unstructured":"Martin, M. G. et al. Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol. Biol. Cell 19, 2101\u20132112 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"864_CR117","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1471-4159.2010.07079.x","volume":"116","author":"AO Sodero","year":"2011","unstructured":"Sodero, A. O. et al. Regulation of tyrosine kinase B activity by the Cyp46\/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging. J. Neurochem. 116, 747\u2013755 (2011).","journal-title":"J. Neurochem."},{"key":"864_CR118","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1113\/JP270590","volume":"594","author":"J Egawa","year":"2016","unstructured":"Egawa, J., Pearn, M. L., Lemkuil, B. P., Patel, P. M. & Head, B. P. Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function. J. Physiol. 594, 4565\u20134579 (2016).","journal-title":"J. Physiol."},{"key":"864_CR119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.biochi.2016.08.014","volume":"130","author":"J Colin","year":"2016","unstructured":"Colin, J. et al. Membrane raft domains and remodeling in aging brain. Biochimie 130, 178\u2013187 (2016).","journal-title":"Biochimie"},{"key":"864_CR120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2018.02.022","volume":"67","author":"M D\u00edaz","year":"2018","unstructured":"D\u00edaz, M., Fabelo, N., Ferrer, I. & Mar\u00edn, R. \u201cLipid raft aging\u201d in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer\u2019s disease. Neurobiol. Aging 67, 42\u201352 (2018).","journal-title":"Neurobiol. Aging"},{"key":"864_CR121","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3233\/JAD-141146","volume":"43","author":"M D\u00edaz","year":"2015","unstructured":"D\u00edaz, M. et al. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1\/A\u03b2PP interaction in early stages of Alzheimer\u2019s disease. J. Alzheimers Dis. 43, 1185\u20131198 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"864_CR122","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick, H. et al. Statins and the risk of dementia. Lancet 356, 1627\u20131631 (2000).","journal-title":"Lancet"},{"key":"864_CR123","doi-asserted-by":"publisher","first-page":"696778","DOI":"10.3389\/fnagi.2021.696778","volume":"13","author":"IA Pikuleva","year":"2021","unstructured":"Pikuleva, I. A. & Cartier, N. Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of action to clinical applications. Front. Aging Neurosci. 13, 696778 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"864_CR124","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2009.04.022","volume":"32","author":"MG Martin","year":"2011","unstructured":"Martin, M. G. et al. Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons. Neurobiol. Aging 32, 933\u2013943 (2011).","journal-title":"Neurobiol. Aging"},{"key":"864_CR125","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nn.3342","volume":"16","author":"L Trovo","year":"2013","unstructured":"Trovo, L. et al. Low hippocampal PI(4,5)P2 contributes to reduced cognition in old mice as a result of loss of MARCKS. Nat. Neurosci. 16, 449\u2013458 (2013).","journal-title":"Nat. Neurosci."},{"key":"864_CR126","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fncel.2015.00407","volume":"9","author":"JJ Brudvig","year":"2015","unstructured":"Brudvig, J. J. & Weimer, J. M. X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease. Front. Cell. Neurosci. 9, 407 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"864_CR127","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-819410-2.00002-3","volume":"184","author":"A Mancini","year":"2022","unstructured":"Mancini, A., de Iure, A. & Picconi, B. Chapter 2 \u2013 Basic mechanisms of plasticity and learning. Handb. Clin. Neurol. 184, 21\u201334 (2022).","journal-title":"Handb. Clin. Neurol."},{"key":"864_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","volume":"44","author":"RC Malenka","year":"2004","unstructured":"Malenka, R. C. & Bear, M. F. LTP and LTD: an embarrassment of riches. Neuron 44, 5\u201321 (2004).","journal-title":"Neuron"},{"key":"864_CR129","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.expneurol.2008.04.019","volume":"212","author":"C Frank","year":"2008","unstructured":"Frank, C. et al. Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp. Neurol. 212, 407\u2013414 (2008).","journal-title":"Exp. Neurol."},{"key":"864_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11081","volume":"7","author":"E Palomer","year":"2016","unstructured":"Palomer, E., Carretero, J., Benvegn\u00f9, S., Dotti, C. G. & Martin, M. G. Neuronal activity controls Bdnf expression via Polycomb de-repression and CREB\/CBP\/JMJD3 activation in mature neurons. Nat. Commun. 7, 11081 (2016).","journal-title":"Nat. Commun."},{"key":"864_CR131","doi-asserted-by":"publisher","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","volume":"33","author":"SM Paul","year":"2013","unstructured":"Paul, S. M. et al. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-d-aspartate receptors. J. Neurosci. 33, 17290\u201317300 (2013).","journal-title":"J. Neurosci."},{"key":"864_CR132","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1073\/pnas.0600316103","volume":"103","author":"TJ Kotti","year":"2006","unstructured":"Kotti, T. J., Ramirez, D. M., Pfeiffer, B. E., Huber, K. M. & Russell, D. W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl Acad. Sci. USA 103, 3869\u20133874 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/srep30928","volume":"6","author":"M Moutinho","year":"2016","unstructured":"Moutinho, M. et al. Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk. Sci. Rep. 6, 30928 (2016).","journal-title":"Sci. Rep."},{"key":"864_CR134","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/jnc.15228","volume":"157","author":"AO Sodero","year":"2021","unstructured":"Sodero, A. O. 24S-hydroxycholesterol: cellular effects and variations in brain diseases. J. Neurochem. 157, 899\u2013918 (2021).","journal-title":"J. Neurochem."},{"key":"864_CR135","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.25642","volume":"87","author":"DM Williams","year":"2020","unstructured":"Williams, D. M., Finan, C., Schmidt, A. F., Burgess, S. & Hingorani, A. D. Lipid lowering and Alzheimer disease risk: a Mendelian randomization study. Ann. Neurol. 87, 30\u201339 (2020).","journal-title":"Ann. Neurol."},{"key":"864_CR136","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1101\/lm.030031.112","volume":"20","author":"GA Rodriguez","year":"2013","unstructured":"Rodriguez, G. A., Burns, M. P., Weeber, E. J. & Rebeck, G. W. Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learn. Mem. 20, 256\u2013266 (2013).","journal-title":"Learn. Mem."},{"key":"864_CR137","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160, 177\u2013190 (2015).","journal-title":"Cell"},{"key":"864_CR138","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10863-018-9757-9","volume":"50","author":"VS Nunes","year":"2018","unstructured":"Nunes, V. S., Cazita, P. M., Catanozi, S., Nakandakare, E. R. & Quint\u00e3o, E. C. R. Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice. J. Bioenerg. Biomembr. 50, 283\u2013287 (2018).","journal-title":"J. Bioenerg. Biomembr."},{"key":"864_CR139","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","volume":"36","author":"C Lane-Donovan","year":"2016","unstructured":"Lane-Donovan, C. et al. Genetic restoration of plasma apoe improves cognition and partially restores synaptic defects in ApoE-deficient mice. J. Neurosci. 36, 10141\u201310150 (2016).","journal-title":"J. Neurosci."},{"key":"864_CR140","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tem.2016.12.001","volume":"28","author":"C Lane-Donovan","year":"2017","unstructured":"Lane-Donovan, C. & Herz, J. ApoE, ApoE receptors, and the synapse in Alzheimer\u2019s disease. Trends Endocrinol. Metab. 28, 273\u2013284 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"864_CR141","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/bs8030033","volume":"8","author":"D Fuentes","year":"2018","unstructured":"Fuentes, D. et al. Age-related changes in the behavior of apolipoprotein E knockout mice. Behav. Sci. 8, 33 (2018).","journal-title":"Behav. Sci."},{"key":"864_CR142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2017.05.042","volume":"403","author":"J Bourbon-Teles","year":"2019","unstructured":"Bourbon-Teles, J. et al. Myelin breakdown in human Huntington\u2019s disease: multi-modal evidence from diffusion MRI and quantitative magnetization transfer. Neuroscience 403, 79\u201392 (2019).","journal-title":"Neuroscience"},{"key":"864_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","volume":"140","author":"SA Reading","year":"2005","unstructured":"Reading, S. A. et al. Regional white matter change in pre-symptomatic Huntington\u2019s disease: a diffusion tensor imaging study. Psychiatry Res. 140, 55\u201362 (2005).","journal-title":"Psychiatry Res."},{"key":"864_CR144","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/mds.20979","volume":"21","author":"HD Rosas","year":"2006","unstructured":"Rosas, H. D. et al. Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: selective white matter pathology and its relationship to clinical measures. Mov. Disord. 21, 1317\u20131325 (2006).","journal-title":"Mov. Disord."},{"key":"864_CR145","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nicl.2018.01.029","volume":"20","author":"HD Rosas","year":"2018","unstructured":"Rosas, H. D. et al. Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease. Neuroimage Clin. 20, 236\u2013242 (2018).","journal-title":"Neuroimage Clin."},{"key":"864_CR146","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1073\/pnas.1818042116","volume":"116","author":"C Ferrari Bardile","year":"2019","unstructured":"Ferrari Bardile, C. et al. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease. Proc. Natl Acad. Sci. USA 116, 9622\u20139627 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR147","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","volume":"31","author":"Z Xiang","year":"2011","unstructured":"Xiang, Z. et al. Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease. J. Neurosci. 31, 9544\u20139553 (2011).","journal-title":"J. Neurosci."},{"key":"864_CR148","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui, L. et al. Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59\u201369 (2006).","journal-title":"Cell"},{"key":"864_CR149","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt, P. et al. Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1\u03b1 in Huntington\u2019s disease neurodegeneration. Cell Metab. 4, 349\u2013362 (2006).","journal-title":"Cell Metab."},{"key":"864_CR150","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-4-3","volume":"4","author":"P Weydt","year":"2009","unstructured":"Weydt, P. et al. The gene coding for PGC-1\u03b1 modifies age at onset in Huntington\u2019s disease. Mol. Neurodegener. 4, 3 (2009).","journal-title":"Mol. Neurodegener."},{"key":"864_CR151","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck, B. N. & Kelly, D. P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615\u2013622 (2006).","journal-title":"J. Clin. Invest."},{"key":"864_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7, e49838 (2012).","journal-title":"PLoS ONE"},{"key":"864_CR153","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","volume":"25","author":"AL Southwell","year":"2016","unstructured":"Southwell, A. L. et al. An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes. Hum. Mol. Genet. 25, 3654\u20133675 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR154","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/mt.2009.175","volume":"18","author":"E Hudry","year":"2010","unstructured":"Hudry, E. et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer\u2019s disease. Mol. Ther. 18, 44\u201353 (2010).","journal-title":"Mol. Ther."},{"key":"864_CR155","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","volume":"24","author":"MA Burlot","year":"2015","unstructured":"Burlot, M. A. et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Hum. Mol. Genet. 24, 5965\u20135976 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"864_CR156","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00401-019-02019-7","volume":"138","author":"C N\u00f3brega","year":"2019","unstructured":"N\u00f3brega, C. et al. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Acta Neuropathol. 138, 837\u2013858 (2019).","journal-title":"Acta Neuropathol."},{"key":"864_CR157","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","volume":"289","author":"N Mast","year":"2014","unstructured":"Mast, N. et al. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J. Biol. Chem. 289, 3529\u20133538 (2014).","journal-title":"J. Biol. Chem."},{"key":"864_CR158","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1074\/jbc.M116.723577","volume":"291","author":"KW Anderson","year":"2016","unstructured":"Anderson, K. W. et al. Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity. J. Biol. Chem. 291, 11876\u201311886 (2016).","journal-title":"J. Biol. Chem."},{"key":"864_CR159","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","volume":"123","author":"N Mast","year":"2017","unstructured":"Mast, N. et al. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer\u2019s disease. Neuropharmacology 123, 465\u2013476 (2017).","journal-title":"Neuropharmacology"},{"key":"864_CR160","doi-asserted-by":"publisher","first-page":"8782","DOI":"10.1096\/fj.201900092R","volume":"33","author":"AM Petrov","year":"2019","unstructured":"Petrov, A. M., Mast, N., Li, Y. & Pikuleva, I. A. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment. FASEB J. 33, 8782\u20138798 (2019).","journal-title":"FASEB J."},{"key":"864_CR161","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong, X. et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat. Neurosci. 17, 694\u2013703 (2014).","journal-title":"Nat. Neurosci."},{"key":"864_CR162","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino, D. E. et al. American Society of Gene and Cell Therapy (ASGCT) working group on AAV integration. Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol. Ther. 30, 2646\u20132663 (2022).","journal-title":"Mol. Ther."},{"key":"864_CR163","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-neuro-111020-100834","volume":"45","author":"RC Challis","year":"2022","unstructured":"Challis, R. C. et al. Adeno-associated virus toolkit to target diverse brain cells. Annu. Rev. Neurosci. 45, 447\u2013469 (2022).","journal-title":"Annu. Rev. Neurosci."},{"key":"864_CR164","doi-asserted-by":"publisher","first-page":"119142","DOI":"10.1016\/j.lfs.2021.119142","volume":"270","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sci. 270, 119142 (2021).","journal-title":"Life Sci."},{"key":"864_CR165","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","volume":"355","author":"L Kang","year":"2023","unstructured":"Kang, L. et al. AAV vectors applied to the treatment of CNS disorders: clinical status and challenges. J. Control. Rel. 355, 458\u2013473 (2023).","journal-title":"J. Control. Rel."},{"key":"864_CR166","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/ph15111430","volume":"15","author":"Y Almoshari","year":"2022","unstructured":"Almoshari, Y. Osmotic pump drug delivery systems \u2013 a comprehensive review. Pharmaceuticals 15, 1430 (2022).","journal-title":"Pharmaceuticals"},{"key":"864_CR167","doi-asserted-by":"publisher","first-page":"eaan2742","DOI":"10.1126\/scitranslmed.aan2742","volume":"10","author":"C Dagdeviren","year":"2018","unstructured":"Dagdeviren, C. et al. Miniaturized neural system for chronic, local intracerebral drug delivery. Sci. Transl. Med. 10, eaan2742 (2018).","journal-title":"Sci. Transl. Med."},{"key":"864_CR168","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.jddst.2020.101628","volume":"57","author":"KMA Spandana","year":"2020","unstructured":"Spandana, K. M. A. et al. A comprehensive review of nano drug delivery system in the treatment of CNS disorders. J. Drug Deliv. Sci. Technol. 57, 101628 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"864_CR169","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1515\/ntrev-2021-0096","volume":"10","author":"AAH Abdellatif","year":"2021","unstructured":"Abdellatif, A. A. H. et al. Nano-scale delivery: a comprehensive review of nano-structured devices, preparative techniques, site-specificity designs, biomedical applications, commercial products, and references to safety, cellular uptake, and organ toxicity. Nanotechnol. Rev. 10, 1493\u20131559 (2021).","journal-title":"Nanotechnol. Rev."},{"key":"864_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","volume":"122","author":"G Tosi","year":"2007","unstructured":"Tosi, G. et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123. J. Control. Rel. 122, 1\u20139 (2007).","journal-title":"J. Control. Rel."},{"key":"864_CR171","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza, M. et al. Cholesterol\u2010loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice. EMBO Mol. Med. 7, 1547\u20131564 (2015).","journal-title":"EMBO Mol. Med."},{"key":"864_CR172","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.03.061","volume":"543","author":"D Belletti","year":"2018","unstructured":"Belletti, D. et al. Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain. Int. J. Pharm. 543, 300\u2013310 (2018).","journal-title":"Int. J. Pharm."},{"key":"864_CR173","doi-asserted-by":"publisher","first-page":"100853","DOI":"10.1016\/j.nantod.2020.100853","volume":"31","author":"T Lammers","year":"2020","unstructured":"Lammers, T. & Ferrari, M. The success of nanomedicine. Nano Today 31, 100853 (2020).","journal-title":"Nano Today"},{"key":"864_CR174","doi-asserted-by":"publisher","first-page":"103699","DOI":"10.1016\/j.ebiom.2021.103699","volume":"74","author":"MN Vu","year":"2021","unstructured":"Vu, M. N., Kelly, H. G., Kent, S. J. & Wheatley, A. K. Current and future nanoparticle vaccines for COVID-19. EBioMedicine 74, 103699 (2021).","journal-title":"EBioMedicine"},{"key":"864_CR175","first-page":"742","volume":"42","author":"C Lee Ventola","year":"2017","unstructured":"Lee Ventola, C. Progress in nanomedicine: approved and investigational nanodrugs. P. T. 42, 742\u2013755 (2017).","journal-title":"P. T."},{"key":"864_CR176","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41565-021-01017-9","volume":"16","author":"EP Stater","year":"2021","unstructured":"Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180\u20131194 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"864_CR177","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41565-021-00901-8","volume":"16","author":"S Friedrichs","year":"2021","unstructured":"Friedrichs, S. & Bowman, D. M. COVID-19 may become nanomedicine\u2019s finest hour yet. Nat. Nanotechnol. 16, 362\u2013364 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"864_CR178","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/pharmaceutics14102195","volume":"14","author":"MP Nikolova","year":"2022","unstructured":"Nikolova, M. P., Kumar, E. M. & Chavali, M. S. Updates on responsive drug delivery based on liposome vehicles for cancer treatment. Pharmaceutics 14, 2195 (2022).","journal-title":"Pharmaceutics"},{"key":"864_CR179","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"U Bulbake","year":"2017","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N. & Khan, W. Liposomal formulations in clinical use: an updated review. Pharmaceutics 9, 12 (2017).","journal-title":"Pharmaceutics"},{"key":"864_CR180","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.apsb.2021.10.009","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharm. Sin. B 12, 2731\u20132739 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"864_CR181","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1023\/A:1008365716693","volume":"11","author":"T Safra","year":"2000","unstructured":"Safra, T. et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m2. Ann. Oncol. 11, 1029\u20131033 (2000).","journal-title":"Ann. Oncol."},{"key":"864_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133569","volume":"10","author":"M Xing","year":"2015","unstructured":"Xing, M., Yan, F., Yu, S. & Shen, P. Efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy in advanced breast cancer: a meta-analysis of ten randomized controlled trials. PLoS ONE 10, e0133569 (2015).","journal-title":"PLoS ONE"},{"key":"864_CR183","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","volume":"11","author":"A Passoni","year":"2020","unstructured":"Passoni, A. et al. Efficacy of cholesterol nose-to-brain delivery for brain targeting in huntington\u2019s disease. ACS Chem. Neurosci. 11, 367\u2013372 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"864_CR184","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/pharmaceutics11100540","volume":"11","author":"SS Hong","year":"2019","unstructured":"Hong, S. S., Oh, K. T., Choi, H. G. & Lim, S. J. Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives. Pharmaceutics 11, 540 (2019).","journal-title":"Pharmaceutics"},{"key":"864_CR185","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"SH Jeong","year":"2023","unstructured":"Jeong, S. H., Jang, J. H. & Lee, Y. B. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J. Pharm. Investig. 53, 119\u2013152 (2023).","journal-title":"J. Pharm. Investig."},{"key":"864_CR186","unstructured":"Birolini, G. Cholesterol Ddysfunction in Huntington\u2019s Disease: Working Toward a Therapeutical Approach. Dissertation, Univ. Milan (2021)."},{"key":"864_CR187","first-page":"55718","volume":"126","author":"LM Lueptow","year":"2017","unstructured":"Lueptow, L. M. Novel object recognition test for the investigation of learning and memory in mice. J. Vis. Exp. 126, 55718 (2017).","journal-title":"J. Vis. Exp."},{"key":"864_CR188","unstructured":"Rodriguiz, R. M., Wetsel, W. C. in Animal Models of Cognitive Impairment (eds Levin, E. D. & Buccafusco, J. J.) Ch. 12 (CRC Press\/Taylor & Francis, 2006)."},{"key":"864_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00402-7","volume":"11","author":"R d\u2019Isa","year":"2021","unstructured":"d\u2019Isa, R., Comi, G. & Leocani, L. Apparatus design and behavioural testing protocol for the evaluation of spatial working memory in mice through the spontaneous alternation T-maze. Sci. Rep. 11, 21177 (2021).","journal-title":"Sci. Rep."},{"key":"864_CR190","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter, A. K., Guest, P. C. & Sarnyai, Z. The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol. Biol. 1916, 105\u2013111 (2019).","journal-title":"Methods Mol. Biol."},{"key":"864_CR191","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees, C. V. & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848\u2013858 (2006).","journal-title":"Nat. Protoc."},{"key":"864_CR192","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/BST20180135","volume":"47","author":"WJ Griffiths","year":"2019","unstructured":"Griffiths, W. J. & Wang, Y. Oxysterol research: a brief review. Biochem. Soc. Trans. 47, 517\u2013526 (2019).","journal-title":"Biochem. Soc. Trans."},{"key":"864_CR193","doi-asserted-by":"publisher","first-page":"eadc9967","DOI":"10.1126\/scitranslmed.adc9967","volume":"14","author":"A Haider","year":"2022","unstructured":"Haider, A. Assessment of cholesterol homeostasis in the living human brain. Sci. Transl. Med. 14, eadc9967 (2022).","journal-title":"Sci. Transl. Med."},{"key":"864_CR194","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0022-2275(20)34891-4","volume":"40","author":"CP Sparrow","year":"1999","unstructured":"Sparrow, C. P. et al. A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro. J. Lipid Res. 40, 1747\u20131757 (1999).","journal-title":"J. Lipid Res."},{"key":"864_CR195","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.chemphyslip.2016.03.003","volume":"199","author":"D W\u00fcstner","year":"2016","unstructured":"W\u00fcstner, D., Modzel, M., Lund, F. W. & Lomholt, M. A. Imaging approaches for analysis of cholesterol distribution and dynamics in the plasma membrane. Chem. Phys. Lipids 199, 106\u2013135 (2016).","journal-title":"Chem. Phys. Lipids"},{"key":"864_CR196","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/002215540205000105","volume":"50","author":"W M\u00f6bius","year":"2002","unstructured":"M\u00f6bius, W. et al. Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J. Histochem. Cytochem. 50, 43\u201355 (2002).","journal-title":"J. Histochem. Cytochem."},{"key":"864_CR197","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/978-90-481-8622-8_22","volume":"51","author":"Y Ohno-Iwashita","year":"2010","unstructured":"Ohno-Iwashita, Y. et al. Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization. Subcell. Biochem. 51, 597\u2013621 (2010).","journal-title":"Subcell. Biochem."},{"key":"864_CR198","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948143","volume":"20","author":"DN Mitroi","year":"2019","unstructured":"Mitroi, D. N. et al. NPC 1 enables cholesterol mobilization during long\u2010term potentiation that can be restored in Niemann\u2013Pick disease type C by CYP 46A1 activation. EMBO Rep. 20, e48143 (2019).","journal-title":"EMBO Rep."},{"key":"864_CR199","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1021\/acs.analchem.0c05399","volume":"93","author":"R Angelini","year":"2021","unstructured":"Angelini, R. et al. Visualizing cholesterol in the brain by on-tissue derivatization and quantitative mass spectrometry imaging. Anal. Chem. 93, 4932\u20134943 (2021).","journal-title":"Anal. Chem."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00864-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00864-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00864-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:03:35Z","timestamp":1695906215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00864-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":199,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1038\/s41582-023-00864-5","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"2 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}